A NEW PLATFORM FOR MEDICINAL AND AROMATIC PLANTS IS RUNNING THANKS TO CDTI AND OUR CERVERA PROJECThttps://www.tricopharming.com/wp-content/themes/osmosis/images/empty/thumbnail.jpg 150 150 marketing marketing https://secure.gravatar.com/avatar/70a32323689d1ac86eb34fe5e14afb1b?s=96&d=mm&r=g
Validation of a biostimulation technology able to increase molecules´ and secondary metabolites concentration both in Artemisia annua plant and other Medicinal and Aromatic Plants.
The project also pretends to test and validate the therapeutic and functional potential of Artennua® extract.
The Centre for the Technological and Industrial Development (CDTI) by Government of Spain, approved our project proposal ‘Validation of a production platform of Biomolecules of Industrial Interest’ presented in the framework of the budgetary line ‘Cervera’. The project, co-funded by EU funds, will last until March 2021 and focuses on different R&D goals. Among them we can find the validation of a biostimulation technology able to increase molecules´ and secondary metabolites concentration both in Artemisia annua plant and other Medicinal and Aromatic Plants species (Cannabis spp, Hypericum, Cnicus benedictus, Artemisia vulgaris, Lavandula). On the other side the project pretends to test and validate the therapeutic and functional potential of our commercial extract Artennua® as food conservative, antioxidant, anti inflammatory, antimicrobian and immune system agent.
Project execution is being guaranteed thanks to the collaboration with two spanish technologic centres belonging to the national centres of the Ministry of Science, Innovation and University network: CTAEx (Agrifood Technology Institute of Extremadura) who is participating in the development of field trials of experimental crops for the technological validation of the platform for the production of biomolecules, and CNTA (National Centre of Food Technology and Safety of Navarra) for the development of in vitro tests with Artennua® in cell cultures to evaluate the therapeutic potential in different applications. Moreover, they have been working on developing a new concentrated formula of Artennua®.
Thanks to CDTI and our achievement at Cervera project, we have been working on our production platform for biomolecules of Industrial interest. We will continue working on the validation of our biostimulation technology in various species of Medicinal and Aromatic plants (MAPs), as well as we have done with Artemisia annua plant.